No Result
View All Result
SUBMIT YOUR ARTICLES
  • Login
Saturday, October 25, 2025
TheAdviserMagazine.com
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
No Result
View All Result
TheAdviserMagazine.com
No Result
View All Result
Home Market Research Business

EU-US trade deal could add up to $19 billion in pharma industry costs, analysts say

by TheAdviserMagazine
3 months ago
in Business
Reading Time: 2 mins read
A A
EU-US trade deal could add up to  billion in pharma industry costs, analysts say
Share on FacebookShare on TwitterShare on LInkedIn


By Bhanvi Satija

(Reuters) -The European Union’s trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 billion as branded medicines become subject to a tariff of 15%, analysts said on Monday.

The added costs could raise prices for consumers unless pharmaceutical companies take action to mitigate the impact of the tariffs, one of the analysts said.

Pharmaceuticals had historically been exempt from duties. Medicines are the largest European exports to the United States by value and the EU accounts for about 60% of all pharmaceutical imports to the U.S.

On Sunday, European officials said that a bilateral trade deal for an across-the-board 15% tariff included pharmaceuticals, except for some generic drugs, which would be subject to no tariffs.

The U.S. has been conducting a national security investigation into the pharmaceutical sector and the industry has been bracing for separate sectoral tariffs. President Donald Trump said earlier this month, before negotiating the bilateral deal, that pharmaceutical tariffs could be as high as 200%.

Some Wall Street analysts said that they do not expect additional tariffs on the EU as a result of the investigation, but others cautioned that the deal was not yet signed and that several questions remained unanswered.

UBS analyst Matthew Weston said that he expects details of the trade deal to include protective measures for EU pharma exports from the U.S. investigation, especially since such measures are being discussed in negotiations with the United Kingdom and Switzerland.

ING analyst Diederik Stadig also said that while tariffs on top of the 15% were not expected, even after the conclusion of the national security investigations, nothing is completely clear “until a trade deal is inked.”

Stadig estimates that these levies could add $13 billion to industry expenses without any mitigation strategies, and some of that could be ultimately borne by the consumer.

Bernstein analyst Courtney Breen puts the additional expenses at $19 billion for the industry, but she notes that companies might be able to absorb some of the costs with the measures they have been implementing — such as stockpiling of drug products and new deals with contract researchers.

Earlier this month, Sanofi said it will sell a manufacturing facility in New Jersey to Thermo Fisher, where the French drugmaker’s therapies will continue to be manufactured. Roche’s CEO Thomas Schinecker said last week that the company was increasing its U.S. inventories to avoid any immediate disruption from tariffs.

Story Continues

UBS’ Weston said that it was not immediately clear which generic drugs were exempted from duties under the deal, but any impact for generic drugmaker Sandoz for this year should mostly be manageable.

Shares in pharmaceutical companies Sanofi, Roche and Sandoz Group all closed up between 0.5% and 1% on Monday.

(Reporting by Bhanvi Satija in Bengaluru; Editing by Alan Barona)



Source link

Tags: AddanalystsBillionCostsdealEUUSindustryPharmatrade
ShareTweetShare
Previous Post

Disability Pride Month: The ADA and the Modern History of Disability Rights in the U.S.

Next Post

Hunter Biden Praised by Joe Rogan, ‘He Could Be President’

Related Posts

edit post
US dollar makes modest weekly gain after soft inflation data

US dollar makes modest weekly gain after soft inflation data

by TheAdviserMagazine
October 25, 2025
0

The U.S. dollar was almost flat on Friday after dipping following fresh inflation data that showed U.S. consumer prices increased...

edit post
Pentagon orders aircraft carrier to Latin America, boosting U.S. military buildup in the region

Pentagon orders aircraft carrier to Latin America, boosting U.S. military buildup in the region

by TheAdviserMagazine
October 24, 2025
0

The U.S. military is sending an aircraft carrier to the waters off South America, the Pentagon announced Friday, in the...

edit post
Social Security COLA 2026: payments to go up 2.8% as inflation cools

Social Security COLA 2026: payments to go up 2.8% as inflation cools

by TheAdviserMagazine
October 24, 2025
0

 The Social Security Administration’s annual cost-of-living adjustment will go up by 2.8% in 2026, translating to an average increase of...

edit post
Ontario quickly caves to Trump and promises to pull the offending Reagan ad that killed Canada trade talks

Ontario quickly caves to Trump and promises to pull the offending Reagan ad that killed Canada trade talks

by TheAdviserMagazine
October 24, 2025
0

President Donald Trump announced he’s ending “all trade negotiations” with Canada because of a television ad sponsored by one of its provinces...

edit post
Microsoft is distancing itself from longtime partner OpenAI, shunning erotica chatbots: ‘Just not a service we’re going to provide,’ AI CEO says

Microsoft is distancing itself from longtime partner OpenAI, shunning erotica chatbots: ‘Just not a service we’re going to provide,’ AI CEO says

by TheAdviserMagazine
October 24, 2025
0

Microsoft will not emulate the strategies of Elon Musk’s xAI or Sam Altman’s OpenAI in creating “simulated erotica” for its...

edit post
Former IndusInd Bank deputy pays 50% of alleged insider trading gains to Sebi

Former IndusInd Bank deputy pays 50% of alleged insider trading gains to Sebi

by TheAdviserMagazine
October 24, 2025
0

IndusInd Bank's former deputy chief has deposited 50% of the alleged insider trading gains with India's markets regulator, BSE said...

Next Post
edit post
Hunter Biden Praised by Joe Rogan, ‘He Could Be President’

Hunter Biden Praised by Joe Rogan, 'He Could Be President'

edit post
10 In-Demand Skills That Make for a Stand-Out Resume

10 In-Demand Skills That Make for a Stand-Out Resume

  • Trending
  • Comments
  • Latest
edit post
77-year-old popular furniture retailer closes store locations

77-year-old popular furniture retailer closes store locations

October 18, 2025
edit post
Pennsylvania House of Representatives Rejects Update to Child Custody Laws

Pennsylvania House of Representatives Rejects Update to Child Custody Laws

October 7, 2025
edit post
What to Do When a Loved One Dies in North Carolina

What to Do When a Loved One Dies in North Carolina

October 8, 2025
edit post
Probate vs. Non-Probate Assets: What’s the Difference?

Probate vs. Non-Probate Assets: What’s the Difference?

October 17, 2025
edit post
California Attorney Pleads Guilty For Role In 2M Ponzi Scheme

California Attorney Pleads Guilty For Role In $912M Ponzi Scheme

October 15, 2025
edit post
Baby Boomers Are Flocking to This Florida Town — but Not for the Weather

Baby Boomers Are Flocking to This Florida Town — but Not for the Weather

October 9, 2025
edit post
Netafim for sale again – Globes

Netafim for sale again – Globes

0
edit post
Wall Street hits records following an encouraging update on inflation

Wall Street hits records following an encouraging update on inflation

0
edit post
Fall 2025 is a Sweet Spot For Investors

Fall 2025 is a Sweet Spot For Investors

0
edit post
US dollar makes modest weekly gain after soft inflation data

US dollar makes modest weekly gain after soft inflation data

0
edit post
Prospect Capital (PSEC) | Monthly Dividend Safety Analysis

Prospect Capital (PSEC) | Monthly Dividend Safety Analysis

0
edit post
Five key takeaways from Friday’s consumer price index report

Five key takeaways from Friday’s consumer price index report

0
edit post
US dollar makes modest weekly gain after soft inflation data

US dollar makes modest weekly gain after soft inflation data

October 25, 2025
edit post
Custodia and Vantage Deliver Tokenization Directly Inside Everyday Banking Systems

Custodia and Vantage Deliver Tokenization Directly Inside Everyday Banking Systems

October 25, 2025
edit post
Bank of England Probes Data Mining Lending Fueling AI Bets

Bank of England Probes Data Mining Lending Fueling AI Bets

October 24, 2025
edit post
Where We Go Next After NY Climate Week

Where We Go Next After NY Climate Week

October 24, 2025
edit post
Pentagon orders aircraft carrier to Latin America, boosting U.S. military buildup in the region

Pentagon orders aircraft carrier to Latin America, boosting U.S. military buildup in the region

October 24, 2025
edit post
Social Security COLA 2026: payments to go up 2.8% as inflation cools

Social Security COLA 2026: payments to go up 2.8% as inflation cools

October 24, 2025
The Adviser Magazine

The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.

CATEGORIES

  • 401k Plans
  • Business
  • College
  • Cryptocurrency
  • Economy
  • Estate Plans
  • Financial Planning
  • Investing
  • IRS & Taxes
  • Legal
  • Market Analysis
  • Markets
  • Medicare
  • Money
  • Personal Finance
  • Social Security
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • US dollar makes modest weekly gain after soft inflation data
  • Custodia and Vantage Deliver Tokenization Directly Inside Everyday Banking Systems
  • Bank of England Probes Data Mining Lending Fueling AI Bets
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • Contact us
  • About Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.